Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Neomycin sulfate manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

neomycin sulfate + dexamethasone sodium phosphate

Ear/eye drops 0.5 % + 0.10 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

This CTD dossier owner and manufacturer, established in the 1980s, operates within South Asia, specializing in the manufacture and supply of pharmaceutical products. Their offerings include tablets, capsules, eye, ear, and nasal drops, as well as oral and injectable suspensions. The company holds EU and US GMP approvals, signifying adherence to high manufacturing standards. Their production lines cater to a diverse range of therapeutic areas, with a focus on infectious diseases, pain management, and ophthalmology. The company boasts a sizable workforce and has a global reach, catering to markets across the world. They are recognized for their commitment to quality, utilizing high-grade chemicals and advanced machinery for production. The company emphasizes its track record in providing quality pharmaceutical products, underscoring its experience in the industry.

Manufacturer usually replies in 2 days

polymyxin b + bacitracin + neomycin sulfate

Cream 5000 units, 400 units, 3400 units

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17459
This pharmaceutical company is a rapidly growing force in the global healthcare market, specializing in high-quality, affordable medications. They boast a diverse product portfolio encompassing prescription drugs, over-the-counter medications, and supplements, targeting key therapy areas like anti-Alzheimer's, asthma, diabetes, and cardiovascular health. The company holds WHO-GMP certifications and international approvals, underscoring their commitment to quality and regulatory compliance. Their manufacturing facilities are equipped with state-of-the-art technology, ensuring the production of safe and effective medicines. They distribute their products widely across multiple regions, including South East Asia and the Middle East, leveraging a robust network of distributors and consignees. Their mission is to provide accessible and affordable healthcare solutions worldwide, aiming to be a trusted partner for high-quality pharmaceuticals globally.

Manufacturer usually replies in 2 days

ketoconazole + clobetasol propionate + neomycin sulfate

Cream 1% + 0.025% + 0.55%

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225

It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 14 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Neomycin Sulfate Manufacturers

Neomycin Sulfate belongs to the class of antibiotics and it is used to reduce the risk of infection during surgery of the bowel. Neomycin Sulfate is also used to reduce the symptoms of hepatic coma. Neomycin Sulfate has been shown to be an effective adjunctive therapy in a hepatic coma by reduction of the ammonia-forming bacteria in the intestinal tract. Neomycin sulfate is also combined with oral erythromycin or metronidazole and given in addition to intravenous prophylaxis. Neomycin Sulfate is Marketed with the brand name Neo-Fradin, Neo-Tab, Neosporin, Mycifradin. Neomycin Sulfate is advised as a prescription product and generic prescription product. Neomycin Sulfate is available in dosage form of Tablet and Solution which are available in dosage strengths of 500 mg /1, 87.5 mg/5mL. Neomycin Sulfate Tablets, USP, for oral administration, contain neomycin sulfate which is an antibiotic obtained from the metabolic products of the actinomycete Streptomyces radiate. Neomycin Sulfate Tablets are taken orally in doses of 4-12 grams of Neomycin Sulfate tablets per day (eight to 24 tablets) in divided doses. Treatment should be continued over a period of five to six days, during which time protein should be returned incrementally to the diet. Neomycin Sulfate Tablets, USP, 500 mg (equivalent to 350 mg of neomycin Sulfate base per tablet) are available as round, off-white, unscored tablets, debossed “500” and “PT”. Neomycin oral solution is available as a clear orange solution available in bottles. The usual recommended adult dose of neomycin sulfate for Hepatic Encephalopathy and Hepatic Coma is 4 to 12 grams orally per day which is taken in divided doses for a duration of 5 to 6 days. Before starting the treatment, protein should be withdrawn from the diet and diuretic agents should be avoided. The usual pediatric dose for bowel preparation is 15 mg/kg orally given which is divided into 3 doses and administered over 10 hours approximately before the operation and after the mechanical bowel preparation. Neomycin Sulfate Oral solution formulations should be stored at 20° C to 25° C (68° F - 77° F).

Wholesale Price of Neomycin Sulfate

The lowest available price for neomycin sulfate 500 mg is around $7.06 for a supply of 6 tablets.

Neomycin Sulfate - Mechanism of action

Neomycin Sulfate is active against both gram-positive and gram-negative organisms, including the major E. coli species resident in the colon as well as the enteropathogenic forms of E. coli. Neomycin Sulfate bactericidal in action. Like other aminoglycosides, neomycin Sulfate inhibits bacterial protein synthesis through irreversible binding to the 30 S ribosomal subunit of susceptible bacteria. Neomycin Sulfate is actively transported into the bacterial cell where it binds to receptors present on the 30 S ribosomal subunit. The bacterial translation is normally initiated by the mRNA binding to the 30S ribosomal subunit and subsequent binding with the 50S subunit for elongation. Neomycin Sulfate is poorly absorbed from the gastrointestinal tract. Gastrointestinal absorption of the drug may be increased if the inflammatory or ulcerative gastrointestinal disease is present.

Finding Neomycin Sulfate Manufacturers and Suppliers

To find an honest partner in our business is one of the big tests and to defeat that test and to make one’s work/life easy in finding the honest manufacturer and supplier of neomycin sulfate one can visit the Pipelinepharma website which helps the buyer in finding the dependable manufacturers and suppliers of neomycin sulfate. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects proprietor with the consumers for the business development. The buyer can filter the product names in user familiar and unified search engine by its country, category, therapeutic area, forms, dossier, and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.